Gigi Davidson, R.Ph., DICVP, Chair of USP's Compounding Expert Committee shares her thoughts and background information on proposed revisions to <797> Pharmaceutical Compounding—Sterile Preparations. Compounding practitioners are encouraged to view and share comments on the changes online.
October is Talk About Your Medicines Month. Sponsored by NCPIE, a USP Convention member organization, this annual opportunity encourages patients and healthcare providers to engage in conversation about medications and their safe use, safe storage, and safe disposal.
Pictograms, a free resource from USP, are simple illustrations that help ensure proper medication use for low-literacy and non-native language speaking patients. They provide healthcare professionals with a useful tool to overcome communication and comprehension issues that may arise.
Nuclear medicine and medical imaging, such as PET scans, have changed how many diseases (e.g., cancer, Alzheimer's) are evaluated and treated. Learn how USP is updating its standards to reflect “state-of-the-industry” practices in this field.
Tiffany Chan, a PharmD candidate from Shenandoah University, details her rewarding experience participating in the 2015 USP Summer Internship Program.
For the first time in more than 20 years, U.S. regulators are considering the reintroduction of bovine (cow-derived) heparin into the U.S., helping to address concerns about potential shortages and adulteration issues associated with this widely-used drug.
Over and under dosing--especially of children--based upon the “teaspoon” dosing instruction, can prolong an illness, compound an existing ailment, and may lead to death. USP has joined a growing chorus of public health organizations and government agencies calling for an end to the teaspoon as a unit of medication dosage measurement.
Today, approximately 80% of all active pharmaceutical ingredients in medicines sold in the U.S. are manufactured in another part of the world. While manufacturers have to ensure the quality and consistency of ingredients that go into final pharmaceutical products, they must also employ measures for the proper control of unwanted impurities in drugs and drug ingredients.